Cosmo Dermatos SRL
Records under this name other than patents Cosmo Dermatos SRL holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,486,458 | Enzymatic Process for Obtaining 17 Alpha-Monoesters of Cortexolone and/or Its 9,11-Dehydroderivatives Formerly held In force · High confidence | In force | High confidence | |
| US 10,716,796 | Enzymatic Process for Obtaining 17 Alpha-Monoesters of Cortexolone And/Or Its 9,11-Dehydroderivatives Formerly held In force · High confidence | In force | High confidence | |
| US 12,337,002 | Enzymatic Process for Obtaining 17 Alpha-Monoesters of Cortexolone And/Or Its 9,11-Dehydroderivatives Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,159,682 | Enzymatic Process for Obtaining 17 Alpha-Monoesters of Cortexolone and/or its 9,11-Dehydroderivatives Formerly held In force · High confidence | In force | High confidence | |
| US 10,166,245 | Enzymatic Process for Obtaining 17 Alpha-Monoesters of Cortexolone And/Or Its 9,11-Dehydroderivatives Formerly held In force · High confidence | In force | High confidence | |
| US 11,938,141 | Enzymatic Process for Obtaining 17 Alpha-Monoesters of Cortexolone And/Or Its 9,11-Dehydroderivatives Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,207,332 | Enzymatic Process for Obtaining 17 Alpha-Monoesters of Cortexolone And/Or Its 9,11-Dehydroderivatives Formerly held In force · High confidence | In force | High confidence | |
| US 9,433,628 | Enzymatic Process for Obtaining 17 Alpha- Monoesters of Cortexolone And/Or Its 9,11- Dehydroderivatives Formerly held In force · High confidence | In force | High confidence | |
| US 8,785,427 | Enzymatic Process for Obtaining 17 Alpha- Monoesters of Cortexolone And/Or Its 9,11- Dehydroderivatives Formerly held In force · High confidence | In force | High confidence | |
| US 8,143,240 | 17ALPHA, 21-Dihydroxypregnene Esters as Antiandrogenic Agents Formerly held Term ended Term ended Jan 12, 2023 · Medium confidence | Term ended | Term ended Jan 12, 2023 | Medium confidence |